ArticleInfectious diseases of poverty2026
Diagnostic challenges of histidine-rich protein 2-based rapid diagnostic tests due to pfhrp2 and pfhrp3 gene deletions in asymptomatic malaria in Tanzania.
Article in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundHistidine-rich protein 2 (HRP2)-based rapid diagnostic tests (RDTs) are critical for malaria diagnosis in Africa, particularly in resource-limited settings. However, the spread of Plasmodium falciparum parasites with pfhrp2 and pfhrp3 gene deletions challenges their effectiveness, raising concerns in affected areas. Therefore, this study aimed to assess the prevalence of pfhrp2 and pfhrp3 gene deletions and evaluate the diagnostic performance of HRP2-based RDTs in detecting asymptomatic malaria infections in Tanzania.
methodThis cross-sectional community survey study aimed to determine the prevalence of pfhrp2/3 gene deletions from asymptomatic malaria population in Tanzania. Moreover, the study intended to assess the performance of HRP2-based RDT and light microscopy (LM) in detecting asymptomatic malaria infections. The survey was conducted from December 2022 to July 2023 in twelve villages (8 villages from high malaria transmission areas and 4 in low endemicity). Diagnosis was done by RDT, LM and quantitative polymerase chain reaction (qPCR). A multiplex qPCR was employed on P. falciparum mono-infection isolates to assess the prevalence of pfhrp2/3 gene deletions. Unpaired t-tests and one-way ANOVA were performed to evaluate associations between log
resultsAmong 3489 participants, RDT detected 710 (77.6%) of 915 qPCR-positive cases, compared to 492 (53.8%) by LM. Compared with qPCR, RDT produced 143 (5.6%) false positives and 205 (22.4%) false negatives, whereas LM had 60 (2.3%) false positives and 423 (46.2%) false negatives. Overall accuracy was similar for RDT (90.0%) and LM (86.2%), with higher sensitivity for RDT. Agreement with qPCR in asymptomatic cases was substantial for RDT (κ = 0.736), whereas it was moderate for LM (κ = 0.590). Multiplex qPCR revealed pfhrp2 or pfhrp3 deletions in 93 (11.8%) of 787 samples, including 19 (2.4%) dual-deletion isolates, all of which were RDT negative. Deletions were more frequent in high-transmission villages (76 cases, 9.7%) than in low-transmission villages (17 cases, 2.2%).
conclusionThe findings support the continued effectiveness of HRP2-based RDTs in detecting asymptomatic P. falciparum infections in Tanzania, despite the presence of some pfhrp2/3 gene deletions. However, the potential increase in deletion prevalence and the limitations of cross-sectional data highlight the need for ongoing molecular surveillance. Collectively, these findings provide a critical foundation for sustained surveillance and for clarifying the epidemiological significance of asymptomatic malaria in Tanzania.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.